Researchers have designed and discovered small molecule compounds and peptides that can bind to the SARS-CoV-specific receptor ACE2, preventing SARS-CoV S protein from binding to ACE2 and fusing with the host cell membrane to prevent viral infection (Zhang et al., 2020). This evidence concerns the gene ACE2 and viral infectious disease.